In fact, murine Maf downregulation results in enhanced antitumor immunity, and human MAF has been detected in tumor-infiltrating macrophages/monocytes and circulating monocytes from non-small cell lung carcinoma (NSCLC) patients [39]. The gene discussed is MAF; the disease is non-small cell lung carcinoma.